Controlled Drugs and Substances Act
Schedule I
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
9.
Moramides, their intermediates, salts, derivatives and salts of intermediates and derivatives including:
(1)
Dextromoramide (d-1-(3-Methyl-4-morpholino-2,2-diphenylbutyryl)pyrrolidine)
UK: MDA Part I Class A Section 1(a) Dextromoramide
UN: Narcotics Part 1 Section 1 Dextromoramide
US: CSA Schedule I Section b Subsection 17 Dextromoramide
PubChem: 92943; ChemSpider: 83901; Wikipedia: Dextromoramide
(2)
Diphenylmorpholinoisovaleric acid (2-Methyl-3-morpholino-1,1-diphenylpropionic acid)
UN: Narcotics Part 1 Section 1 Moramide intermediate
US: CSA Schedule II Section c Subsection 17 Moramide-intermediate
PubChem: 567581; ChemSpider: 493453; Wikipedia: Moramide intermediate
(3)
Levomoramide (l-1-(3-Methyl-4-morpholino-2,2-diphenylbutyryl)pyrrolidine)
UK: MDA Part I Class A Section 1(a) Levomoramide
UN: Narcotics Part 1 Section 1 Levomoramide
US: CSA Schedule I Section b Subsection 32 Levomoramide
PubChem: 10453145; ChemSpider: 8628561; Wikipedia: Levomoramide
(4)
Racemoramide (dl-1-(3-Methyl-4-morpholino-2,2-diphenylbutyryl)pyrrolidine)
UK: MDA Part I Class A Section 1(a) Racemoramide
UN: Narcotics Part 1 Section 1 Racemoramide
US: CSA Schedule I Section b Subsection 52 Racemoramide
PubChem: 9648; ChemSpider: 9269; Wikipedia: Racemoramide
11 March 2016 · Creative Commons BY-NC-SA ·